FDA Clearance Tracker · K232216
Hemoblock_S (Prescription); Hemoblock_S (OTC)
Last checked: Nov 19, 2026Latest source record: Apr 19, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Apr 19, 2024
Substantially Equivalent
Time to decision
268 days
Received Jul 26, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Unclassified
The decision
- FDA number
- K232216
- Device name
- Hemoblock_S (Prescription); Hemoblock_S (OTC)
- Applicant
- Incore Co., Ltd.
- Applicant location
- Daegu, KR
- Received
- Jul 26, 2023
- Decided
- Apr 19, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Unclassified
- Specialty
- General & Plastic SurgeryWound Care
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QSY. The earliest in FDA's data is K893123, decided Feb 13, 1990.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K232216
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Incore Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- CORE-INJECTOR510(k)
K221054 · Decided Dec 21, 2022 · 254 days after receipt
Device type: Endoscopic Injection Needle, Gastroenterology-Urology (FBK) · GI, Urology & Nephrology
- CORE-SNARE510(k)
K220846 · Decided Nov 21, 2022 · 243 days after receipt
Device type: Snare, Flexible (FDI) · GI, Urology & Nephrology
- CORE-SPORT510(k)
K220081 · Decided Sep 28, 2022 · 261 days after receipt
Device type: Laparoscopic Single Port Access Device (OTJ) · GI, Urology & Nephrology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.